BlackRock Amends DaVita Stake, Updates Ownership as of Dec 31, 2023
Ticker: DVA · Form: SC 13G/A · Filed: Jan 31, 2024 · CIK: 927066
| Field | Detail |
|---|---|
| Company | Davita Inc. (DVA) |
| Form Type | SC 13G/A |
| Filed Date | Jan 31, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, healthcare, passive-investment
TL;DR
**BlackRock updated its DaVita stake, showing its holdings as of year-end 2023.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 31, 2024, indicating its ownership of DaVita Inc. common stock as of December 31, 2023. This filing, Amendment No. 8, updates their previous disclosures regarding their stake in the healthcare services company. This matters to investors because BlackRock is a major institutional investor, and changes in their reported holdings can signal shifts in their investment strategy or outlook on DaVita's future performance.
Why It Matters
This filing shows BlackRock's updated position in DaVita, providing transparency on a significant institutional investor's holdings, which can influence market perception and trading decisions.
Risk Assessment
Risk Level: low — This is a routine amendment filing by a large institutional investor and does not inherently signal a high-risk event for the company.
Analyst Insight
An investor should note that BlackRock, a major institutional holder, has updated its position in DaVita. While this filing doesn't disclose the exact change in share count or percentage, it confirms their continued interest as of year-end 2023. Investors should look for the detailed ownership percentage within the full filing to understand the magnitude of BlackRock's stake and any changes from previous reports.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- DAVITA INC. (company) — the subject company whose common stock is being reported
- December 31, 2023 (date) — the date of the event which requires the filing of this statement
- January 31, 2024 (date) — the date the SC 13G/A was filed
- Amendment No: 8 (number) — the specific amendment number of this filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 8)' sections.
Who is the 'Subject Company' in this filing?
The 'Subject Company' is DAVITA INC., identified by 'COMPANY CONFORMED NAME: DAVITA INC.' and 'Name of Issuer: DAVITA INC' in the filing.
Who is the 'Filed By' entity in this document?
The 'Filed By' entity is BlackRock Inc., as indicated by 'COMPANY CONFORMED NAME: BlackRock Inc.' in the 'FILED BY' section.
What is the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' is December 31, 2023, as explicitly stated in the filing.
What is the CUSIP Number for the securities reported?
The CUSIP Number for the Common Stock of DAVITA INC. is 23918K108, as listed under '(CUSIP Number)'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 31, 2024 regarding DAVITA INC. (DVA).